USNA
USANA HEALTH SCIENCES INC
Company overview
- Market capitalization
- $273.82M
- Employees
- 1,570
- Latest publication
- 2026-09-29
About USANA HEALTH SCIENCES INC
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Financial statements
Income Quarterly
| Metric | Q2 20262026-07-04 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 223,273,000USD | 250,218,000USD | 226,200,000USD | 213,670,000USD | 235,848,000USD | 249,539,000USD | 213,613,000USD | 200,221,000USD |
| Cost Of Revenue | 48,339,000USD | 59,436,000USD | 49,408,000USD | 48,815,000USD | 57,927,000USD | 60,784,000USD | 42,552,000USD | 42,826,000USD |
| Gross Profit | 174,934,000USD | 190,782,000USD | 176,792,000USD | 164,855,000USD | 177,921,000USD | 188,755,000USD | 171,061,000USD | 157,395,000USD |
| Selling General Administrative | 82,318,000USD | 88,254,000USD | 78,081,000USD | 85,947,000USD | 81,906,000USD | 91,438,000USD | 73,348,000USD | 61,295,000USD |
| Total Operating Expenses | 194,930,000USD | 176,908,000USD | 159,543,000USD | 163,631,000USD | 161,203,000USD | 173,084,000USD | 162,851,000USD | 141,794,000USD |
| Operating Income | -19,996,000USD | 13,874,000USD | 17,249,000USD | 1,224,000USD | 16,718,000USD | 15,671,000USD | 8,210,000USD | 15,601,000USD |
| Total Other Income Expense Net | 1,096,000USD | 1,591,000USD | -13,072,000USD | 570,000USD | 2,099,000USD | 1,068,000USD | 2,219,000USD | 3,007,000USD |
| Interest Income | 595,000USD | 437,000USD | 495,000USD | 578,000USD | 619,000USD | 723,000USD | 2,738,000USD | 3,142,000USD |
| Interest Expense | 0USD | 240,000USD | 123,000USD | 49,000USD | 259,000USD | 411,000USD | 129,000USD | 49,000USD |
| Income Before Tax | -18,900,000USD | 15,465,000USD | 4,177,000USD | 1,794,000USD | 18,817,000USD | 16,739,000USD | 10,429,000USD | 18,608,000USD |
| Income Tax Expense | 9,051,000USD | 8,506,000USD | 5,772,000USD | 8,456,000USD | 8,372,999USD | 7,449,000USD | 5,945,000USD | 8,001,000USD |
| Net Income | -27,951,000USD | 7,515,000USD | -1,775,000USD | -6,522,000USD | 9,655,000USD | 9,402,000USD | 4,484,000USD | 10,607,000USD |
| Unclassified Operating Expenses | — | 88,654,000USD | 81,462,000USD | 77,684,000USD | 79,297,000USD | 81,646,000USD | 77,932,000USD | 80,499,000USD |
| Net Interest Income | — | 197,000USD | 372,000USD | 529,000USD | 360,000USD | 312,000USD | 2,609,000USD | 3,093,000USD |
| Tax Provision | — | 8,506,000USD | 5,772,000USD | 8,456,000USD | 8,373,000USD | 7,449,000USD | 5,945,000USD | 8,001,000USD |
| Net Income From Continuing Ops | — | 6,959,000USD | -1,595,000USD | -6,662,000USD | 10,444,000USD | 9,290,000USD | 4,484,000USD | 10,607,000USD |
| Ebit | — | 15,705,000USD | 4,300,000USD | 1,843,000USD | 19,076,000USD | 17,150,000USD | 10,558,000USD | 18,657,000USD |
| Ebitda | — | 25,494,000USD | 14,586,000USD | 11,410,000USD | 28,680,000USD | 27,395,000USD | 16,442,000USD | 24,216,000USD |
| Depreciation And Amortization | — | 9,789,000USD | 10,286,000USD | 9,567,000USD | 9,604,000USD | 10,245,000USD | 5,884,000USD | 5,559,000USD |
| Reconciled Depreciation | — | 9,789,000USD | 10,286,000USD | 9,567,000USD | 9,604,000USD | 10,245,000USD | 5,884,000USD | 5,559,000USD |
| Minority Interest | — | — | -180,000USD | 140,000USD | -789,000USD | — | — | — |
| Research Development | — | — | — | — | — | — | 11,571,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 925,257,000USD | 854,503,000USD | 921,010,000USD | 998,601,000USD | 1,186,464,000USD | 1,134,644,000USD | 1,060,902,000USD | 1,189,248,000USD |
| Cost Of Revenue | 200,852,000USD | 175,751,000USD | 189,395,000USD | 193,890,000USD | 217,898,000USD | 209,111,000USD | 187,503,000USD | 200,710,000USD |
| Gross Profit | 724,405,000USD | 678,752,000USD | 731,615,000USD | 804,711,000USD | 968,566,000USD | 925,533,000USD | 873,399,000USD | 988,538,000USD |
| Selling General Administrative | 337,372,000USD | 258,301,000USD | 256,989,000USD | 262,304,000USD | 279,107,000USD | 261,186,000USD | 267,731,000USD | 275,059,000USD |
| Unclassified Operating Expenses | 336,171,000USD | 342,556,000USD | 370,109,000USD | 423,230,000USD | 508,155,000USD | 477,223,000USD | 449,219,000USD | 516,284,000USD |
| Total Operating Expenses | 673,543,000USD | 612,428,000USD | 638,544,000USD | 697,097,000USD | 798,374,000USD | 749,042,000USD | 727,209,000USD | 800,185,000USD |
| Operating Income | 50,862,000USD | 66,324,000USD | 93,071,000USD | 107,614,000USD | 170,192,000USD | 176,491,000USD | 146,190,000USD | 188,353,000USD |
| Interest Income | 2,415,000USD | 11,319,000USD | 8,191,000USD | 3,789,000USD | 2,515,000USD | 2,535,000USD | 4,707,000USD | 4,427,000USD |
| Interest Expense | 842,000USD | 281,000USD | 262,000USD | 192,000USD | 57,000USD | 507,000USD | 66,000USD | 36,000USD |
| Net Interest Income | 1,573,000USD | 11,038,000USD | 8,042,000USD | 3,597,000USD | 2,458,000USD | 2,028,000USD | 4,641,000USD | 4,391,000USD |
| Income Before Tax | 41,527,000USD | 76,351,000USD | 102,453,000USD | 108,621,000USD | 170,642,000USD | 177,948,000USD | 150,496,000USD | 191,510,000USD |
| Income Tax Expense | 30,050,000USD | 34,291,000USD | 38,665,000USD | 39,271,000USD | 54,137,000USD | 53,284,000USD | 49,970,000USD | 65,286,000USD |
| Tax Provision | 30,050,000USD | 34,291,000USD | 38,827,000USD | 39,271,000USD | 54,137,000USD | 53,284,000USD | 49,970,000USD | 65,286,000USD |
| Net Income | 10,760,000USD | 42,030,000USD | 63,788,000USD | 69,350,000USD | 116,505,000USD | 124,664,000USD | 100,526,000USD | 126,224,000USD |
| Net Income From Continuing Ops | 11,477,000USD | 42,060,000USD | 59,817,000USD | 69,350,000USD | 116,505,000USD | 124,664,000USD | 100,526,000USD | 126,224,000USD |
| Ebit | 42,369,000USD | 76,632,000USD | 102,715,000USD | 107,614,000USD | 170,192,000USD | 176,491,000USD | 146,190,000USD | 188,353,000USD |
| Ebitda | 82,071,000USD | 98,861,000USD | 123,110,000USD | 129,024,000USD | 192,385,000USD | 199,000,000USD | 169,197,000USD | 205,196,000USD |
| Depreciation And Amortization | 39,702,000USD | 22,229,000USD | 20,395,000USD | 21,410,000USD | 22,193,000USD | 22,509,000USD | 23,007,000USD | 16,843,000USD |
| Reconciled Depreciation | 39,702,000USD | 22,229,000USD | 20,776,000USD | 21,410,000USD | 22,193,000USD | 22,509,000USD | 23,007,000USD | 16,843,000USD |
| Total Other Income Expense Net | -9,335,000USD | 10,027,000USD | 9,382,000USD | 1,007,000USD | 450,000USD | 1,457,000USD | 4,306,000USD | 3,157,000USD |
| Minority Interest | -717,000USD | -30,000USD | 0USD | — | — | — | — | — |
| Research Development | — | 11,571,000USD | 11,446,000USD | 11,563,000USD | 11,112,000USD | 10,633,000USD | 10,259,000USD | 8,842,000USD |
| Net Income Applicable To Common Shares | — | — | — | 69,350,000USD | 116,505,000USD | 124,664,000USD | 100,526,000USD | 126,224,000USD |
| Non Operating Income Net Other | — | — | — | — | 507,000USD | 1,964,000USD | 4,372,000USD | 3,193,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-07-04 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 703,210,000USD | 738,966,000USD | 742,915,000USD | 726,591,000USD | 734,526,000USD | 746,596,000USD | 748,193,000USD | 671,308,000USD |
| Cash And Equivalents | 168,560,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 281,066,000USD | 294,233,000USD | 288,405,000USD | 264,065,000USD | 261,866,000USD | 281,394,000USD | 279,187,000USD | 451,191,000USD |
| Other Current Assets | 22,826,000USD | 25,467,000USD | 18,312,000USD | 27,935,000USD | 27,259,000USD | 28,224,000USD | 19,461,000USD | 22,318,000USD |
| Other Non Current Assets | 64,580,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 132,237,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 105,675,000USD | 117,239,000USD | 128,565,000USD | 118,664,000USD | 121,625,000USD | 137,383,000USD | 139,625,000USD | 114,779,000USD |
| Other Current Liabilities | 90,244,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 21,900,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 526,306,000USD | 543,550,000USD | 533,104,000USD | 528,073,999USD | 531,060,000USD | 529,762,000USD | 532,109,000USD | 533,087,000USD |
| Total Equity Including Noncontrolling Interest | 570,973,000USD | — | — | — | — | — | — | — |
| Inventory | 86,343,000USD | 96,358,000USD | 102,608,000USD | 90,781,000USD | 83,269,000USD | 73,557,000USD | 69,735,000USD | 63,984,000USD |
| Property Plant Equipment Net | 94,269,000USD | 94,625,000USD | 94,383,000USD | 96,212,000USD | 96,532,000USD | 94,245,000USD | 94,565,000USD | 98,033,000USD |
| Goodwill | 109,141,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 124,615,000USD | 128,901,000USD | 133,151,000USD | 138,159,000USD | 142,747,000USD | 147,157,000USD | 151,823,000USD | 29,237,000USD |
| Accounts Payable | 15,431,000USD | 16,230,000USD | 17,263,000USD | 17,095,000USD | 17,899,000USD | 13,974,000USD | 11,984,000USD | 7,041,000USD |
| Common Stock | 18,000USD | 18,000USD | 18,000USD | 18,000USD | 18,000USD | 19,000USD | 19,000USD | 19,000USD |
| Retained Earnings | 451,853,000USD | 473,235,000USD | 465,720,000USD | 467,495,000USD | 474,017,000USD | 477,628,000USD | 478,944,000USD | 474,490,000USD |
| Accumulated Other Comprehensive Income | -13,676,000USD | -14,436,000USD | -16,178,000USD | -19,289,000USD | -19,349,000USD | -22,752,000USD | -22,670,000USD | -13,699,000USD |
| Total Liab | — | 144,180,000USD | 156,643,000USD | 145,038,000USD | 148,968,000USD | 162,723,000USD | 161,861,000USD | 138,221,000USD |
| Other Current Liab | — | 87,009,000USD | 97,302,000USD | 101,569,000USD | 103,726,000USD | 100,409,000USD | 74,819,000USD | 107,738,000USD |
| Capital Stock | — | 18,000USD | 18,000USD | 18,000USD | 18,000USD | 19,000USD | 19,000USD | 19,000USD |
| Good Will | — | 138,127,000USD | 137,962,000USD | 144,288,000USD | 144,230,000USD | 144,218,000USD | 144,168,000USD | 17,196,000USD |
| Cash | — | 162,751,000USD | 158,380,000USD | 145,349,000USD | 151,338,000USD | 179,613,000USD | 181,768,000USD | 364,889,000USD |
| Cash And Short Term Investments | — | 162,751,000USD | 158,380,000USD | 145,349,000USD | 151,338,000USD | 179,613,000USD | 181,768,000USD | 364,889,000USD |
| Net Debt | — | -148,751,000USD | -144,380,000USD | -145,349,000USD | -151,338,000USD | -156,613,000USD | -142,564,000USD | -364,889,000USD |
| Short Term Debt | — | 14,000,000USD | 14,000,000USD | — | — | 23,000,000USD | 29,013,000USD | — |
| Short Long Term Debt | — | 14,000,000USD | 14,000,000USD | — | — | 23,000,000USD | 23,000,000USD | — |
| Short Long Term Debt Total | — | 14,000,000USD | 14,000,000USD | — | — | 23,000,000USD | 39,204,000USD | — |
| Net Receivables | — | 9,657,000USD | 9,105,000USD | — | — | — | 8,223,000USD | — |
| Common Stock Shares Outstanding | — | 18,411,000shares | 18,302,000shares | 18,293,000shares | 18,536,000shares | 19,085,000shares | 19,104,000shares | 19,083,000shares |
| Non Current Assets Total | — | 444,733,000USD | 454,510,000USD | 462,526,000USD | 472,660,000USD | 465,202,000USD | 469,006,000USD | 220,117,000USD |
| Non Current Liabilities Total | — | 26,941,000USD | 28,078,000USD | 26,374,000USD | 27,343,000USD | 25,340,000USD | 22,236,000USD | 23,442,000USD |
| Non Current Liabilities Other | — | 21,884,000USD | 23,186,000USD | 21,907,000USD | 22,681,000USD | 20,539,000USD | 18,163,000USD | 18,715,000USD |
| Non Currrent Assets Other | — | 35,015,000USD | 58,945,000USD | 63,867,000USD | 39,928,000USD | 37,985,000USD | 56,066,000USD | 35,976,000USD |
| Net Working Capital | — | 176,994,000USD | 159,840,000USD | 145,401,000USD | 140,241,000USD | 144,011,000USD | 139,562,000USD | 336,412,000USD |
| Unclassified Non Current Assets | — | 48,065,000USD | 30,069,000USD | 20,000,000USD | 49,223,000USD | 41,597,000USD | 22,384,000USD | 39,675,000USD |
| Unclassified Current Liabilities | — | -14,000,000USD | -14,000,000USD | — | — | -23,000,000USD | -11,241,000USD | — |
| Unclassified Non Current Liabilities | — | 5,057,000USD | 4,892,000USD | 4,467,000USD | 4,662,000USD | 4,801,000USD | 4,073,000USD | 4,727,000USD |
| Unclassified Equity | — | 84,715,000USD | 83,526,000USD | 79,831,999USD | 76,356,000USD | 74,848,000USD | 75,797,000USD | 72,258,000USD |
| Property Plant Equipment Gross | — | — | 228,961,000USD | — | — | — | 224,653,000USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | 12,050,000USD | — |
| Other Assets | — | — | — | — | — | — | — | -58,828,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 742,915,000USD | 748,193,000USD | 632,757,000USD | 596,549,000USD | 577,740,000USD | 640,887,000USD | 516,933,999USD | 554,463,000USD |
| Intangible Assets | 133,151,000USD | 151,823,000USD | 29,919,000USD | 32,432,000USD | 30,442,000USD | 30,796,000USD | 29,840,000USD | 31,811,000USD |
| Other Current Assets | 27,417,000USD | 19,461,000USD | 18,671,000USD | 18,503,000USD | 17,534,000USD | 12,691,000USD | 15,111,000USD | 18,491,000USD |
| Total Liab | 156,643,000USD | 161,861,000USD | 135,555,000USD | 162,077,000USD | 182,616,000USD | 199,237,000USD | 165,222,000USD | 163,317,000USD |
| Total Stockholder Equity | 533,104,000USD | 532,109,000USD | 497,202,000USD | 434,472,000USD | 395,124,000USD | 441,650,000USD | 351,712,000USD | 391,146,000USD |
| Other Current Liab | 97,302,000USD | 74,819,000USD | 74,273,000USD | 100,044,000USD | 115,374,000USD | 117,548,999USD | 95,112,000USD | 117,971,000USD |
| Common Stock | 18,000USD | 19,000USD | 19,000USD | 19,000USD | 19,000USD | 21,000USD | 22,000USD | 24,000USD |
| Capital Stock | 18,000USD | 19,000USD | 19,000USD | 19,000USD | 19,000USD | 21,000USD | 22,000USD | 24,000USD |
| Retained Earnings | 465,720,000USD | 478,944,000USD | 445,217,000USD | 391,636,000USD | 344,637,000USD | 382,794,000USD | 306,146,000USD | 329,501,000USD |
| Good Will | 137,962,000USD | 144,168,000USD | 17,102,000USD | 17,368,000USD | 17,668,000USD | 17,367,000USD | 16,636,000USD | 16,815,000USD |
| Cash | 158,380,000USD | 181,768,000USD | 330,420,000USD | 288,420,000USD | 239,832,000USD | 312,875,000USD | 234,830,000USD | 214,326,000USD |
| Cash And Short Term Investments | 158,380,000USD | 181,768,000USD | 330,420,000USD | 288,420,000USD | 239,832,000USD | 312,875,000USD | 234,830,000USD | 277,865,000USD |
| Total Current Assets | 288,405,000USD | 279,187,000USD | 417,746,000USD | 381,225,000USD | 362,847,000USD | 423,210,000USD | 327,608,000USD | 392,335,000USD |
| Total Current Liabilities | 128,565,000USD | 139,625,000USD | 118,845,000USD | 143,833,000USD | 160,790,000USD | 168,073,000USD | 136,098,000USD | 148,686,000USD |
| Net Debt | -144,380,000USD | -142,564,000USD | -317,215,000USD | -274,636,000USD | -222,537,000USD | -291,403,000USD | -209,233,000USD | -214,326,000USD |
| Short Term Debt | 14,000,000USD | 29,013,000USD | 8,064,000USD | 6,892,000USD | 7,080,000USD | 8,616,000USD | 8,323,000USD | 20,768,000USD |
| Short Long Term Debt | 14,000,000USD | 23,000,000USD | 786,000USD | — | — | — | — | — |
| Short Long Term Debt Total | 14,000,000USD | 39,204,000USD | 13,205,000USD | 13,784,000USD | 17,295,000USD | 21,472,000USD | 25,597,000USD | — |
| Inventory | 102,608,000USD | 69,735,000USD | 61,454,000USD | 67,089,000USD | 98,318,000USD | 90,224,000USD | 68,905,000USD | 81,948,000USD |
| Accounts Payable | 17,263,000USD | 11,984,000USD | 10,070,000USD | 11,049,000USD | 13,508,000USD | 18,195,000USD | 12,525,000USD | 9,947,000USD |
| Property Plant Equipment Net | 111,539,000USD | 94,565,000USD | 99,814,000USD | 117,770,000USD | 125,569,000USD | 128,392,000USD | 126,496,000USD | 92,025,000USD |
| Property Plant Equipment Gross | 228,961,000USD | 224,653,000USD | 228,753,000USD | 222,521,000USD | 101,780,000USD | 100,445,000USD | 126,496,000USD | 92,025,000USD |
| Accumulated Other Comprehensive Income | -16,178,000USD | -22,670,000USD | -13,695,000USD | -12,787,000USD | 458,000USD | -3,625,000USD | -13,901,000USD | -10,387,000USD |
| Common Stock Shares Outstanding | 18,574,000shares | 19,162,000shares | 19,345,000shares | 19,310,000shares | 20,343,000shares | 21,256,000shares | 22,818,000shares | 24,642,000shares |
| Non Current Assets Total | 454,510,000USD | 469,006,000USD | 215,011,000USD | 215,323,999USD | 214,893,000USD | 217,676,999USD | 189,325,999USD | 162,128,000USD |
| Non Current Liabilities Total | 28,078,000USD | 22,236,000USD | 16,710,000USD | 18,244,000USD | 21,826,000USD | 31,163,999USD | 29,123,999USD | 14,631,000USD |
| Non Current Liabilities Other | 23,186,000USD | 18,163,000USD | 12,158,000USD | 14,173,000USD | 14,329,000USD | 19,155,000USD | 18,842,000USD | 1,264,000USD |
| Non Currrent Assets Other | 51,858,000USD | 56,066,000USD | 52,066,000USD | 35,054,999USD | 12,554,000USD | 33,419,999USD | 10,405,999USD | 15,221,000USD |
| Net Working Capital | 159,840,000USD | 139,562,000USD | 298,901,000USD | 240,549,000USD | 204,327,000USD | 257,213,000USD | 193,181,000USD | 243,649,000USD |
| Unclassified Non Current Assets | 20,000,000USD | 22,384,000USD | 16,109,999USD | -37,979,000USD | -34,073,000USD | -59,291,000USD | -20,224,000USD | -17,668,000USD |
| Unclassified Current Liabilities | -14,000,000USD | -11,241,000USD | 11,742,000USD | 4,973,000USD | 5,193,000USD | 7,761,001USD | 6,286,000USD | -15,055,000USD |
| Unclassified Non Current Liabilities | 4,892,000USD | 4,073,000USD | 4,552,000USD | -6,493,000USD | -21,826,000USD | -12,009,001USD | -11,850,001USD | -14,631,000USD |
| Unclassified Equity | 83,526,000USD | 75,797,000USD | 65,642,000USD | 55,585,000USD | 49,991,000USD | 62,439,000USD | 59,423,000USD | 71,984,000USD |
| Current Deferred Revenue | — | 12,050,000USD | 13,910,000USD | 20,875,000USD | 19,635,000USD | 15,952,000USD | 13,852,000USD | 15,055,000USD |
| Net Receivables | — | 8,223,000USD | 7,201,000USD | 7,213,000USD | 7,163,000USD | 7,420,000USD | 8,762,000USD | 14,031,000USD |
| Other Assets | — | — | 1USD | 50,678,000USD | 62,733,000USD | 66,993,000USD | 26,172,000USD | 23,924,000USD |
| Other Liab | — | — | — | 10,564,000USD | 21,826,000USD | 12,009,000USD | 11,850,000USD | 14,631,000USD |
| Net Tangible Assets | — | — | — | 384,672,000USD | 347,014,000USD | 441,650,000USD | 305,236,000USD | 342,520,000USD |
| Deferred Long Term Liab | — | — | — | — | 7,497,000USD | 12,009,000USD | 10,282,000USD | 13,367,000USD |
| Short Term Investments | — | — | — | — | — | — | 0USD | 63,539,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-07-04 · USD |
|---|---|
| Depreciation | 15,951,000USD |
| Stock Based Compensation | 6,858,000USD |
| Deferred Income Tax | -3,224,000USD |
| Change To Account Receivables | 959,000USD |
| Change To Inventory | 9,421,000USD |
| Change To Liabilities | -11,850,000USD |
| Change In Working Capital | -755,000USD |
| Operating Cash Flow | 33,078,000USD |
| Capital Expenditures | -5,800,000USD |
| Unclassified Investing Cash Flow | -854,000USD |
| Investing Cash Flow | -6,654,000USD |
| Net Common Stock Issuance | -2,291,000USD |
| Other Financing Activities | -1,376,000USD |
| Unclassified Financing Cash Flow | -14,000,000USD |
| Financing Cash Flow | -17,667,000USD |
| Effect Of Forex Changes On Cash | 1,511,000USD |
| Change In Cash | 10,268,000USD |
| End Cash Flow | 171,508,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 7,515,000USD | -1,595,000USD | -6,662,000USD | 10,444,000USD | 9,290,000USD | 4,484,000USD | 10,607,000USD | 10,432,000USD |
| Depreciation | 9,789,000USD | 10,286,000USD | 9,567,000USD | 9,604,000USD | 10,245,000USD | 5,884,000USD | 5,559,000USD | 5,702,000USD |
| Stock Based Compensation | 3,454,000USD | 3,750,000USD | 3,576,000USD | 3,622,000USD | 2,880,000USD | 3,613,000USD | 3,542,000USD | 3,734,000USD |
| Other Non Cash Items | 4,210,000USD | 5,014,000USD | 465,000USD | 863,000USD | 1,211,000USD | 2,000USD | 361,000USD | 190,000USD |
| Change To Account Receivables | -5,367,000USD | — | — | — | 1,004,000USD | — | — | — |
| Change To Inventory | 6,597,000USD | -13,542,000USD | -8,155,000USD | -8,067,000USD | -4,921,000USD | 1,676,000USD | 692,000USD | -2,685,000USD |
| Change In Working Capital | -13,863,000USD | -18,174,000USD | -10,930,000USD | -4,475,000USD | -9,499,000USD | -5,501,000USD | 8,594,000USD | -4,603,000USD |
| Total Cash From Operating Activities | 9,759,000USD | -3,390,000USD | -1,961,000USD | 12,218,000USD | 15,482,000USD | 5,785,000USD | 29,534,000USD | 7,990,000USD |
| Capital Expenditures | -2,645,000USD | -2,795,000USD | -3,198,000USD | -5,027,000USD | -2,803,000USD | -1,802,000USD | -2,399,000USD | -2,671,000USD |
| Free Cash Flow | 7,114,000USD | -6,185,000USD | -5,159,000USD | 7,191,000USD | 12,679,000USD | 3,983,000USD | 27,135,000USD | 5,319,000USD |
| Investments | 0USD | 0USD | -3,198,000USD | -4,162,000USD | -3,875,000USD | -205,138,000USD | -2,338,000USD | -1,546,000USD |
| Total Cashflows From Investing Activities | -2,597,000USD | 1,110,000USD | -3,198,000USD | -4,162,000USD | -3,875,000USD | -205,138,000USD | -2,338,000USD | -1,546,000USD |
| Net Borrowings | 0USD | 14,000,000USD | 0USD | -23,000,000USD | 0USD | 23,004,000USD | 1,000USD | — |
| Total Cash From Financing Activities | -3,641,000USD | 13,453,000USD | -979,000USD | -38,610,000USD | -14,467,000USD | 22,930,000USD | -78,000USD | -1,353,000USD |
| Sale Purchase Of Stock | 0USD | 0USD | 0USD | -15,207,000USD | -12,300,000USD | -74,000USD | -79,000USD | -31,000USD |
| Change In Cash | 4,371,000USD | 13,087,000USD | -5,973,000USD | -28,241,000USD | -2,141,000USD | -183,233,000USD | 32,566,000USD | 4,069,000USD |
| Begin Period Cash Flow | 158,380,000USD | 148,153,000USD | 154,126,000USD | 182,367,000USD | 184,508,000USD | 367,741,000USD | 335,175,000USD | 331,106,000USD |
| End Period Cash Flow | 162,751,000USD | 161,240,000USD | 148,153,000USD | 154,126,000USD | 182,367,000USD | 184,508,000USD | 367,741,000USD | 335,175,000USD |
| Other Cashflows From Financing Activities | -3,641,000USD | -547,000USD | -979,000USD | -403,000USD | -2,167,000USD | -74,000USD | -79,000USD | -31,000USD |
| Unclassified Operating Cash Flow | -1,346,000USD | -2,671,000USD | 2,023,000USD | -7,840,000USD | 1,355,000USD | -2,697,000USD | — | -7,465,000USD |
| Other Cashflows From Investing Activities | — | 3,905,000USD | -1,072,000USD | 865,000USD | -1,072,000USD | -203,336,000USD | 61,000USD | 1,125,000USD |
| Unclassified Investing Cash Flow | — | — | 4,270,000USD | 4,162,000USD | 3,875,000USD | 205,138,000USD | 2,338,000USD | 1,546,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | -1,291,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 10,760,000USD | 42,060,000USD | 63,788,000USD | 69,350,000USD | 116,505,000USD | 124,664,000USD | 100,526,000USD | 126,224,000USD |
| Depreciation | 32,562,000USD | 22,229,000USD | 20,395,000USD | 21,410,000USD | 22,193,000USD | 22,509,000USD | 23,007,000USD | 16,843,000USD |
| Stock Based Compensation | 13,828,000USD | 14,558,000USD | 14,595,000USD | 13,485,000USD | 14,298,000USD | 14,394,000USD | 15,541,000USD | 14,955,000USD |
| Other Non Cash Items | 15,410,000USD | 1,892,000USD | 2,611,000USD | 6,069,000USD | 61,000USD | 701,000USD | 84,000USD | 1,147,000USD |
| Change To Inventory | -34,685,000USD | -2,118,000USD | 2,353,000USD | 15,797,000USD | -10,501,000USD | -16,784,000USD | 12,990,000USD | -23,101,000USD |
| Change In Working Capital | -43,078,000USD | -13,003,000USD | -27,999,000USD | 771,000USD | -28,860,000USD | 556,000USD | -8,790,000USD | -7,749,000USD |
| Total Cash From Operating Activities | 22,349,000USD | 60,992,000USD | 70,641,000USD | 103,902,000USD | 121,227,000USD | 160,401,000USD | 126,733,000USD | 152,119,000USD |
| Capital Expenditures | -13,823,000USD | -10,073,000USD | -14,494,000USD | -10,400,000USD | -12,763,000USD | -15,094,000USD | -16,569,000USD | -11,433,000USD |
| Free Cash Flow | 8,526,000USD | 50,919,000USD | 56,147,000USD | 93,502,000USD | 108,464,000USD | 145,307,000USD | 110,164,000USD | 140,686,000USD |
| Investments | -1,072,000USD | -213,090,000USD | -7,935,000USD | -12,370,000USD | -1,439,000USD | -18,873,000USD | 64,046,000USD | -57,951,000USD |
| Total Cashflows From Investing Activities | -10,125,000USD | -213,090,000USD | -11,975,000USD | -12,370,000USD | -14,187,000USD | -33,961,000USD | 47,494,000USD | -69,003,000USD |
| Net Borrowings | -9,000,000USD | 22,220,000USD | 792,000USD | 0USD | 0USD | -46,000USD | -65,000USD | — |
| Total Cash From Financing Activities | -40,603,000USD | 9,553,000USD | -14,237,000USD | -30,088,000USD | -181,412,000USD | -59,442,000USD | -152,052,000USD | -105,277,000USD |
| Sale Purchase Of Stock | -27,507,000USD | -9,444,000USD | -11,599,000USD | -25,382,000USD | -177,837,000USD | -57,029,000USD | -150,000,000USD | -105,375,000USD |
| Change In Cash | -23,268,000USD | -148,738,000USD | 41,926,000USD | 47,667,000USD | -72,284,000USD | 78,249,000USD | 20,454,000USD | -33,301,000USD |
| Begin Period Cash Flow | 184,508,000USD | 333,246,000USD | 291,320,000USD | 243,653,000USD | 315,937,000USD | 237,688,000USD | 217,234,000USD | 250,535,000USD |
| End Period Cash Flow | 161,240,000USD | 184,508,000USD | 333,246,000USD | 291,320,000USD | 243,653,000USD | 315,937,000USD | 237,688,000USD | 217,234,000USD |
| Other Cashflows From Investing Activities | 3,698,000USD | 64,000USD | 15,000USD | 7,000USD | 131,000USD | 281,000USD | 231,000USD | 4,849,000USD |
| Other Cashflows From Financing Activities | -4,096,000USD | -3,223,000USD | -3,430,000USD | -4,706,000USD | -3,575,000USD | -2,367,000USD | -1,987,000USD | 98,000USD |
| Unclassified Operating Cash Flow | -7,133,000USD | -6,744,000USD | -2,749,000USD | -7,183,000USD | -2,970,000USD | -2,423,000USD | -3,635,000USD | — |
| Unclassified Investing Cash Flow | 1,072,000USD | 10,009,000USD | 10,439,000USD | 10,393,000USD | — | — | — | -4,468,000USD |
| Change To Liabilities | — | — | — | -2,656,000USD | -16,028,000USD | 22,532,000USD | -28,969,000USD | 16,978,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -74,372,000USD | 66,998,000USD | 22,175,000USD | -22,161,000USD |
| Change To Account Receivables | — | — | — | — | — | 281,000USD | 231,000USD | -658,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Segment | All Other | 17,834,000 | USD | 0000896264-26-000021 |
| FY 2025Yearly · 2025-12-31 | Segment | Core Nutritional | 775,452,000 | USD | 0000896264-26-000021 |
| FY 2025Yearly · 2025-12-31 | Segment | Hiya | 131,971,000 | USD | 0000896264-26-000021 |
| Q3 2025Quarterly · 2025-09-30 | Segment | All Other | 6,999,000 | USD | 0000896264-25-000224 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Direct Selling | 175,825,000 | USD | 0000896264-25-000224 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Hiya | 30,846,000 | USD | 0000896264-25-000224 |
| Q2 2025Quarterly · 2025-06-30 | Segment | All Other | 2,789,000 | USD | 0000896264-25-000205 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Direct Selling | 199,128,000 | USD | 0000896264-25-000205 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Hiya | 33,931,000 | USD | 0000896264-25-000205 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Core Nutritional | 210,824,000 | USD | 0000896264-26-000034 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Hiya | 37,089,000 | USD | 0000896264-26-000034 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Rise | 2,390,000 | USD | 0000896264-26-000034 |
| FY 2024Yearly · 2024-12-31 | Segment | All Other | 6,744,000 | USD | 0000896264-26-000021 |
| FY 2024Yearly · 2024-12-31 | Segment | Core Nutritional | 845,789,000 | USD | 0000896264-26-000021 |
| FY 2024Yearly · 2024-12-31 | Segment | Hiya | 1,970,000 | USD | 0000896264-26-000021 |
| Q4 2024Quarterly · 2024-12-31 | Segment | All Other | 1,677,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Direct Selling | 209,966,000 | USD | Legacy provider |
| Q3 2024Quarterly · 2024-09-30 | Segment | All Other | 1,754,000 | USD | 0000896264-25-000224 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Direct Selling | 198,467,000 | USD | 0000896264-25-000224 |
| Q2 2024Quarterly · 2024-06-30 | Segment | All Other | 1,661,000 | USD | 0000896264-25-000205 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Direct Selling | 211,208,000 | USD | 0000896264-25-000205 |
| Q1 2024Quarterly · 2024-03-31 | Segment | All Other | 1,652,000 | USD | 0000896264-25-000126 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Direct Selling | 226,148,000 | USD | 0000896264-25-000126 |
| FY 2023Yearly · 2023-12-31 | Segment | All Other | 5,798,000 | USD | 0000896264-26-000021 |
| FY 2023Yearly · 2023-12-31 | Segment | Core Nutritional | 915,212,000 | USD | 0000896264-26-000021 |
| Q4 2023Quarterly · 2023-12-31 | Segment | All Other | 1,478,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Direct Selling | 219,605,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Segment | All Other | 3,559,000 | USD | 0000896264-25-000092 |
| FY 2022Yearly · 2022-12-31 | Segment | Direct Selling | 995,042,000 | USD | 0000896264-25-000092 |
| FY 2021Yearly · 2021-12-31 | Segment | All Other | 0 | USD | 0000896264-24-000093 |
| FY 2021Yearly · 2021-12-31 | Segment | Direct Selling | 1,186,464,000 | USD | 0000896264-24-000093 |
| FY 2020Yearly · 2020-12-31 | Segment | All Other | 0 | USD | 0000896264-23-000004 |
| FY 2020Yearly · 2020-12-31 | Segment | Direct Selling | 1,134,644,000 | USD | 0000896264-23-000004 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.